These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 12851465)
1. Diabetes mellitus in the era of proteomics. Korc M Mol Cell Proteomics; 2003 Jun; 2(6):399-404. PubMed ID: 12851465 [No Abstract] [Full Text] [Related]
2. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. 1992. Hales CN; Barker DJ Int J Epidemiol; 2013 Oct; 42(5):1215-22. PubMed ID: 24159065 [No Abstract] [Full Text] [Related]
3. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance]. Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269 [TBL] [Abstract][Full Text] [Related]
4. Advances in insulin sensitizers. Lohray BB; Bhushan V Curr Med Chem; 2004 Sep; 11(18):2467-503. PubMed ID: 15379708 [TBL] [Abstract][Full Text] [Related]
5. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice. Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225 [TBL] [Abstract][Full Text] [Related]
6. Obesity and diabetes mellitus--how are they linked? Boden G West Indian Med J; 2002 Mar 7-10; 51 Suppl 1():51-4. PubMed ID: 12050976 [TBL] [Abstract][Full Text] [Related]
7. [PPAR family and its relationship to metabolic syndrome]. Zhang XY; Chen LH; Guan YF Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):6-12. PubMed ID: 15881336 [TBL] [Abstract][Full Text] [Related]
8. Chain of events. Curry A Diabetes Forecast; 2014 Nov; 67(11):84-5. PubMed ID: 25571761 [No Abstract] [Full Text] [Related]
9. Insulin resistance as the core defect in type 2 diabetes mellitus. Goldstein BJ Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance. Patsouris D; Müller M; Kersten S Curr Opin Investig Drugs; 2004 Oct; 5(10):1045-50. PubMed ID: 15535425 [TBL] [Abstract][Full Text] [Related]
11. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology? Patti ME Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):383-90. PubMed ID: 15192439 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Jay MA; Ren J Curr Diabetes Rev; 2007 Feb; 3(1):33-9. PubMed ID: 18220654 [TBL] [Abstract][Full Text] [Related]
13. [The significance of leptin for the pathogenesis of diabetes mellitus type 2. Direct effects on endocrine pancreas]. Seufert J Internist (Berl); 1999 Aug; 40(8):894-7. PubMed ID: 10532844 [No Abstract] [Full Text] [Related]
14. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism. Yahia RB; Lichnovská R; Brychta T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus. Viana Abranches M; Esteves de Oliveira FC; Bressan J Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962 [TBL] [Abstract][Full Text] [Related]
16. Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes? Corkey BE Diabetes Care; 2012 Dec; 35(12):2432-7. PubMed ID: 23173132 [No Abstract] [Full Text] [Related]
19. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592 [TBL] [Abstract][Full Text] [Related]
20. Daniel Porte Jr.: A Leader in Our Understanding of the Role of Defective Insulin Secretion and Action in Obesity and Type 2 Diabetes. Palmer JP; Kahn SE; Schwartz MW; Taborsky GJ; Woods SC Diabetes Care; 2020 Apr; 43(4):704-709. PubMed ID: 32198285 [No Abstract] [Full Text] [Related] [Next] [New Search]